ml-3000 has been researched along with chir-265 in 1 studies
| Studies (ml-3000) | Trials (ml-3000) | Recent Studies (post-2010) (ml-3000) | Studies (chir-265) | Trials (chir-265) | Recent Studies (post-2010) (chir-265) |
|---|---|---|---|---|---|
| 130 | 9 | 56 | 33 | 1 | 31 |
| Protein | Taxonomy | ml-3000 (IC50) | chir-265 (IC50) |
|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.6095 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.14 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.006 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.02 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.0501 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.02 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.02 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for ml-3000 and chir-265
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |